National Genetics Institute (NGI) is a company that provides genetics testing services for blood screening, medical testing, and clinical research. It offers assays for human immunodeficiency virus (HIV), hepatitis A, B, and C (HAV, HBV, and HCV) viruses and other infectious agents. In addition, NGI is a provider of nucleic acid screening services to the global biotechnology industry. The company also provides genetic testing services to physicians, hospitals, and clinics and has supported numerous pharmaceutical and biotechnology companies in the clinical development of infectious disease and oncology therapies.